BioversityMA, a new workforce training non-profit spun out of MassBio, which trains underrepresented and low-income Boston area residents to pursue early career roles at local life sciences companies, is hosting their inaugural fundraising event July 31, Celebrate Bioversity! https://lnkd.in/eFG-NJtx Join us to: - Celebrate Bioversity's first six months in operation - Hear from graduates, employers, and champions, including MassBio Board Chair Tamar Thompson Buy a ticket today: https://lnkd.in/eDbpGrRu Bioversity Inc. is a 501c3 public charity. All ticket purchases and donations to Bioversity are fully tax deductible.
MassBio
Biotechnology Research
Cambridge, Massachusetts 33,428 followers
Massachusetts is the State of Possible - the #1 life sciences cluster in the world - and we plan to keep it that way!
About us
MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts life sciences industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing more than 1000 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and healthcare, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.
- Website
-
http://www.massbio.org
External link for MassBio
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Nonprofit
- Founded
- 1985
Locations
-
Primary
700 Technology Sq
5th Floor
Cambridge, Massachusetts 02139, US
Employees at MassBio
-
Carolina Alarco
Biotech/Medtech Executive and Board Member, Strategic Consultant, Investment Banking, Angel Investor
-
Joel Kahn MD, NBC-HWC
Innovation driven health executive
-
Joseph Murphy
Founder and President at immunePCS, LLC
-
Rita McAteer
Accomplished marketing, communications and fundraising leader.
Updates
-
In the late summer of 2022, the MassBio leadership team was invited by Beacon Capital Properties to visit their redeveloped life sciences campus in Dorchester, Southline Boston, to talk about the prospect of MassBio opening and running a workforce training center in their building. Fast forward to January 8, 2024, and Bioversity’s doors opened for the first cohort of 18 students. Since then BioversityMA has graduated three cohorts and just started their fourth. They are meeting their mission of intentionally recruiting underrepresented and low-income students from Boston neighborhoods and surrounding communities. In the first class, 78% were Boston residents, 100% identified as either Black or Latino (or both); 56% were female, and the average age was 31. Bioversity is wrapping up six months, with a dramatic start and lots of room for growth. Read more from Executive Director Zach Stanley: https://lnkd.in/e44q2e8m Meet the Bioversity community by joining us on July 31 for their inaugural fundraising event: Celebrate Bioversity! https://lnkd.in/eFG-NJtx
-
Thank you to all of the organizations hosting events with us at the #MassBioHub! We love supporting our members' off-site meetings, team workshops, Pharma Day®, and more. #HubHappenings Beacon Therapeutics | Browne Consulting | Cellarity | Daiichi Sankyo US | Fulcrum Therapeutics | Myeloid Therapeutics | Ticket to Biotech
-
-
The FDA is launching a new Rare Disease Innovation Hub to help them to better understand and more effectively advance therapeutics, medical devices and diagnostic tests for very small patient populations (https://lnkd.in/eEZxW-Qt). This is exciting news for the #raredisease patients waiting for treatments and the #biotechs looking to deliver them. MassBio Board Chair Tamar Thompson, a longtime rare disease champion and Head, Corporate Affairs at Alexion Pharmaceuticals, Inc./AstraZeneca Rare Disease: “We applaud the FDA for this significant step forward in creating a more equitable environment for rare disease patients and their families. This achievement is also a testament to the tireless efforts of patient advocacy organizations, clinical-stage and small biotech companies collaborating with the FDA to advance innovation. At MassBio, we recognize the critical role these companies have played in driving the progress that the Rare Disease Innovation Hub represents. “There is much more work to be done, and we look forward to serving as a champion for the biotech community, a partner for rare disease patients, and a resource to the FDA.” #patientdriven #FDA #rarediseases #rarediseasecommunity
FDA announces rare disease hub in bid to streamline treatment paths
https://endpts.com
-
BioversityMA's inaugural summer fundraising event is July 31: https://lnkd.in/eFG-NJtx We'll celebrate the launch of Bioversity's workforce training center in Dorchester, the completion of their first three training cohorts, and hear inspiring stories from graduates, employers, and champions. Thank you to the Gold Sponsors: Blueprint Medicines | Foundation Medicine | Johnson & Johnson When you sponsor this uplifting event, you aren’t just donating resources toward operations, you're helping to open doors for hundreds of underrepresented and overlooked people by ensuring Bioversity’s sustainable and ambitious future. Contact Bioversity's Executive Director Zach Stanley for more details.
-
-
Did you join us earlier this year at the MassBio State of Possible Conference 2024? If you missed it or want to look back, you can find all of the session recordings on MB Vision - including remarks from Congressman Jake Auchincloss. In his speech, he spoke to Massachusetts’ historic tendency to be a national leader, asserting that the state’s approach to biotechnology should not be any different. He conveyed the need for American leadership in biotechnology innovation, calling on his colleagues in Congress to prioritize biotechnology the same way semiconductor technologies and production were prioritized. Watch the full recording on #MBVision https://lnkd.in/efgUy8Gc. #StateOfPossible24
-
We're pretty fond of our newest #MassBioMembers. Can you show them some love on this #WelcomeWednesday? Amplitude Therapeutics is a seed-staged biotechnology company focusing on developing the next generation of RNAs to fully unlock the therapeutic potential of RNA biology. GreenLabs Recycling collects and recycles non-hazardous plastic consumables from labs, recognizing that by keeping recycling local, we can make it effective in terms of cost and environmental sustainability. ImaginAb is a clinical stage, revenue-generating global biotechnology company developing the next generation of imaging agents and radiopharmaceutical therapy (RPT) products. IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences is one of the most successful Czech research institutions, recognized globally. This year, it established its first laboratory in the United States right here in Cambridge. IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Jett Foundation empowers people and families impacted by Duchenne muscular dystrophy through the development of transformative programming, educational opportunities, and ongoing support. Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to safely and precisely restoring health in patients with severe conditions. seqWell creates scalable genomics technologies that simplify workflows and help enable every life scientist to unlock transformative discoveries with sequencing. Skylark Bio, Cambridge MA Skylark Bio, a gene therapy company, exists to create a world where anyone, anywhere can experience life in all its sensory dimensions. Vindhya Data Science is an innovative data science company specializing in bioinformatics, genomics, machine learning, artificial intelligence, structural biology and the full spectrum of computational biology. Viva Biotech provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. We're so excited to have you join the MassBio community!
-
Today, MassBio and The Termeer Foundation announced the launch of “CEO & Founder Link,” a dedicated network for founders and CEOs of emerging #lifesciences companies (Press Release: https://lnkd.in/eFCczR4Y). Through quarterly engagements, the two influential organizations will provide leaders with networking, education around key topics, and a peer community with whom they can collaborate. Founders and CEOs are invited to apply through an online portal to attend events where you will feel empowered and safe to share best practices, workshop challenges, and forge lasting connections. Apply now: https://lnkd.in/edatZS3J.
-
-
It was so much fun hosting Ticket to Biotech's regional meetup in the #MassBioHub! Appreciate the opportunity to host so many of the industry's storytellers to network and exchange business cards, as well as complete a service project with Life Science Cares Boston. Thanks to our friends at The Castle Group and #MassBioMember AbbVie for sponsoring. Looking forward to hosting future events that bring together the people and teams who help the #biopharma industry share our #patientdriven stories. Stay tuned! #T2Bmeet
Thanks to everyone who came out this week to support Life Science Cares Boston and our community for T2Bmeet @ Boston! Such a great turnout for a summer morning, including three of our fabulous ad board members- Sarah MacDonald, Trista Morrison, NACD.DC, and Cynthia Clayton. We couldn’t have done it without our amazing hosts, Ryan Boehm, Benjamin Bradford and the MassBio team, and generous sponsors, The Castle Group and AbbVie! Special thanks to the Castle crew who came out in force to join us for our first Boston event- David Tanklefsky, Sandy Lish, Danielle Dickinson, CMP, Justin Auguste. If you missed this one, don’t worry- there will be more in Boston and other biopharma hubs. Have a fantastic weekend!
-
BioversityMA is positively impacting the lives of their graduates and the Massachusetts life sciences community. Join their inaugural fundraising event on July 31: https://lnkd.in/eFG-NJtx. Reach out to Zach Stanley to learn more about sponsoring this event and the program.
CEO & President, MassBio | Chair, Bioversity | Board, The Boston Foundation | Vice Chair, American Cancer Society (ACS) Eastern New England | Board, MassBioEd Foundation
Launching BioversityMA was a leap of faith. Opening the physical doors was a thrill. Seeing the tangible impact on the lives of residents? Priceless. After just 6 months, it’s incredible to be able to celebrate the 43 individuals who have graduated, many who have been hired. But doing this work—training the students, paying their stipends and expenses, keeping the lights on—has a cost to it. What is the value of bringing new talent into the local #lifesciences workforce and making progress in our responsibility to be an inclusive industry? Join us on July 31 as we celebrate Bioversity’s progress and raise funds for its future (Tickets: https://lnkd.in/e8eigKMz). Bioversity’s future is now linked to the futures of the passionate individuals who want to make a difference for patients while they make a difference for themselves and their families. Buy a ticket. Make a donation. Be a sponsor. MassBio | Zach Stanley | Ross Marshall #bioversity #workforcedevelopment #workforcetraining #nonprofit